Skip to main content
. 2013 Feb 5;5:41–49. doi: 10.2147/HIV.S32377

Table 1.

Summary data from the ECHO and THRIVE Phase III studies

THRIVE
ECHO
Combined information
EFV RPV EFV RPV EFV RPV
Number of patients 340 340 344 346 682 686
Virologic failures (%) 5 7 6 13 9 13
Virologic response (48 weeks) (%) 82 86 83 83 82 84
CD4 count increase (48 weeks) 263 263 257 240

Abbreviations: EFV, efavirenz; RPV, rilpivirine.